Cartalax 20mg

46.50

Availability: Available on back-order SKU: CARTALAX-20mg Categories: , Tags: , ,

Cartalax 20mg

46.50

In stock

Description

Cartalax is a synthetic peptide complex studied in laboratory environments for its role in cartilage tissue research, joint structure signalling, and regenerative biology models. It is typically classified within a group of short peptides investigated for their interaction with connective tissue and cellular repair pathways.

In controlled experimental settings, Cartalax has been explored for its potential influence on cartilage regeneration processes, extracellular matrix signalling, and joint tissue maintenance mechanisms.

As demand increases for pure peptides in Ireland and across Europe, Cartalax is commonly included in research focusing on:

  • Cartilage and joint tissue models
  • Connective tissue regeneration research
  • Extracellular matrix signalling pathways
  • Structural tissue repair mechanisms

This product is supplied as a high-purity research peptide, intended strictly for scientific and laboratory use.

Disclaimer: This product is strictly for research purposes only and is not for human consumption.

Technical Information – Cartalax

Specification Details
Product Name Cartalax
Compound Type Synthetic peptide complex
Functional Class Connective tissue research peptide
Primary Focus Cartilage and joint tissue research
Mechanism Under investigation (cellular and extracellular signalling)
Biological Targets Chondrocytes, extracellular matrix pathways
Format Lyophilised powder
Purity Research-grade (high purity)
Storage Refrigerated (2–8°C, protected from light)
Application Laboratory research use only

* Images for illustration purposes only

Researched Benefits & Focus Areas – Cartalax

1. Cartilage Regeneration Research

Cartalax has been studied in models involving:

  • Cartilage repair and regeneration processes
  • Chondrocyte activity and signalling pathways
  • Structural tissue development in joint models

Reference basis: Derived from preclinical studies on peptide-based modulation of cartilage tissue and chondrocyte function.


2. Connective Tissue & Extracellular Matrix Support

Research has explored Cartalax in:

  • Extracellular matrix (ECM) signalling pathways
  • Collagen synthesis and structural integrity models
  • Connective tissue repair mechanisms

Reference basis: Based on biochemical research into peptide interactions with connective tissue and ECM regulation.


3. Joint Function & Structural Research

Cartalax is of interest in:

  • Joint tissue maintenance studies
  • Mechanical stress and recovery models
  • Structural integrity of cartilage under load

Reference basis: Supported by experimental studies examining joint tissue biology and structural peptide signalling.


4. Cellular Repair & Regenerative Signalling

  • Investigated for cellular repair signalling pathways
  • Explored in tissue regeneration and recovery models
  • Potential role in cellular communication within connective tissues

Reference basis: Derived from molecular biology research into peptide-mediated cellular repair mechanisms.


Disclaimer: These are research-based findings only. This product is not intended for human use or consumption.

Researched Risks & Considerations – Cartalax

1. Limited Clinical Research

  • Primarily studied in preclinical and laboratory settings
  • Limited human data available
  • Long-term effects remain uncertain

Reference basis: Reflects the current early-stage status of peptide complexes in connective tissue research.


2. Complex Biological Interactions

  • May influence multiple tissue signalling pathways
  • Potential for unintended interactions in experimental models

Reference basis: Based on research into peptide interaction across connective tissue systems.


3. Tissue-Specific Variability

  • Effects may vary depending on tissue type and experimental conditions
  • Requires controlled laboratory analysis

Reference basis: Derived from studies highlighting variability in connective tissue response to peptide signalling.


4. Regulatory Classification

  • Not approved for medical or therapeutic use
  • Classified strictly as a research compound
  • Requires controlled laboratory handling

Reference basis: Based on regulatory frameworks governing research peptides in EU and international markets.


Disclaimer: These risks are based on available research data only. This product is strictly a research peptide and not for human consumption.

Additional information

Weight 23 kg
Dimensions 12 × 23 × 56 cm
Quantity

1 Vial, 1 Kit (10 Vials)

Related Products

FEATURED PRODUCTS

BEST SELLING PRODUCTS

LATEST PRODUCTS

Retatrutide 10mg

100.00

Vilon 20mg

35.00

Vesugen 20mg

35.00

TOP RATED PRODUCTS

Acetic Acid 10ml

11.99

Retatrutide 10mg

100.00

Vilon 20mg

35.00